Covid is not over by a long shot, page-73

@Starlink please read the study overview below and then re-read the final results announcement. The primary endpoint of the trail was not achieved, therefore the trial FAILED....

Please stop spreading false truths that this trial did not fail to meet it's intended end points.

Results in the trial did show some benefits it certain age cohorts so it was not all negative. But the FACT remains that the primary endpoint WAS NOT REACHED

Study Overview

The randomised, double-blinded, placebo-controlled clinical study of VIRALEZE™ assesses SARS-CoV-2 viral load in the nasal cavity of patients with COVID-19 while using VIRALEZE™. The primary endpoint of the clinical study is the level of a patient’s viral load over a seven-day treatment period.